THE CHECKPOINTS were born in 2007 on an escalator in Chicago. Here's the story…
Anne-Marie Langevin, of the South Texas Pediatric Minority/Underserved NCI Community Oncology Research Program site in San Antonio, won the 2018 Harry Hynes Award, which is given annually to the PI who reflects the outstanding contribution to clinical trials and community research.
As the fallout from the ethics scandal at Memorial Sloan Kettering Cancer Center continues, cancer center officials are investigating allegations contained in an anonymous letter from a group that identifies themselves as “Concerned Employees of MSKCC.”
Oregon flirts with—and quickly abandons—plan to deny Medicaid payment for next-generation sequencing
The Oregon Health Authority did a considerable amount of work to prepare a plan that would deny Medicaid coverage for next-generation sequencing tests in the state.
Matthew Ong spoke with Richard Goldberg.
Matthew Ong spoke with John Stewart.
The Oregon Health Authority is weighing a recommendation to deny Medicaid coverage for next-generation sequencing tests in the state.
Historically, oncology drug development has evolved on what may seem to be a different planet, at least relative to mainstream clinical pharmacology.
The U.S. Senate Sept. 18 passed a conference “minibus” appropriations package that will increase the NIH budget by $2 billion to $39.1 billion—a 5.4 percent boost over the current level.
José Baselga, who has resigned from his positions as physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center, is winding down his research and clinical activities at that institution, officials said.
